Amino acid mutation in
Dhfr; dhps; drug resistance markers; Hormozgan; Iran; mutation
Plasmodium vivax
Journal
Journal of vector borne diseases
ISSN: 0972-9062
Titre abrégé: J Vector Borne Dis
Pays: India
ID NLM: 101212761
Informations de publication
Date de publication:
Historique:
entrez:
10
8
2019
pubmed:
10
8
2019
medline:
18
12
2019
Statut:
ppublish
Résumé
Molecular analysis of antifolate resistance-associated genes-dihydrofolate reductase (dhfr) and dihydropteroate synthetase (dhps) of Plasmodium vivax is important in predicting the emergence of drug resistance to sulphadoxine-pyrimethamine (SP). The present study aimed to determine the polymorphism of dhfr and dhps genes in P. vivax field isolates. Samples from 80 microscopically diagnosed vivax malaria cases were collected from endemic areas of malaria in Hormozgan Province of Iran, from June 2010 to November 2015. The two sets of codons at position 33, 57, 58, 117, 173 of dhfr and 382, 383, and 553 of dhps genes were analysed by direct sequencing of PCR products. The majority of the isolates (70%) harboured a wild-type allele for P. vivax dhfr (Pvdhfr) and P. vivax dhps (Pvdhps). Mutations were detected in three codons of Pvdhfr (P33L, S58R and S117N) and single codon in Pvdhps (A383G). Novel mutations that have not been identified previously at codon 459 (D459A) of Pvdhps were also observed. The high prevalence of point mutation as well as the rising triple mutation of Pvdhfr and Pvdhps genotypes necessitate change in programmes and guidelines to eliminate P. vivax in future.
Identifiants
pubmed: 31397394
pii: JVectorBorneDis_2019_56_2_170_263716
doi: 10.4103/0972-9062.263716
doi:
Substances chimiques
Antimalarials
0
Protozoan Proteins
0
Tetrahydrofolate Dehydrogenase
EC 1.5.1.3
Dihydropteroate Synthase
EC 2.5.1.15
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
170-173Déclaration de conflit d'intérêts
None